Table 2 Prevalence of Metabolic Syndrome and Component Disorders among Participants with and without HIV
Metabolic Condition | PLHIV | PWoH | ||||||
|---|---|---|---|---|---|---|---|---|
N | Estimate | 95% CI | N | Estimate | 95% CI | |||
Metabolic Syndrome | 440 | 30.7% | 26.4% | 35.2% | 232 | 22.8% | 17.6% | 28.8% |
High Blood Pressure | 440 | 22.3% | 18.5% | 26.5% | 232 | 20.3% | 15.3% | 26.0% |
Diabetes Mellitus | 440 | 20.5% | 16.8% | 24.5% | 232 | 8.2% | 5.0% | 12.5% |
Prediabetes | 440 | 33.8% | 29.5% | 38.5% | 232 | 21.1% | 16.1% | 26.9% |
Abdominal Obesity (WC) | 438 | 38.4% | 33.8% | 43.1% | 232 | 37.1% | 30.8% | 43.6% |
Abdominal Obesity (WHR) | 438 | 42.6% | 38.0% | 47.5% | 232 | 40.1% | 33.7% | 46.7% |
High Triglycerides | 437 | 24.5% | 20.5% | 28.8% | 232 | 17.2% | 12.6% | 22.7% |
Low HDL-C | 437 | 51.1% | 46.4% | 55.9% | 232 | 41.4% | 35.0% | 48.0% |